STRATAGEM - New diagnostic and therapeutic tools against multidrug resistant tumors

Datos básicos

Código:

EU22/13

Dotación:

Año Inicial:

2022

Año final:

2022

Objetivos del proyecto

The main aim is to find new biomarkers predictive/diagnostic of MDR (multidrug resistance) that can be suitable therapeutic targets; and to design and validate new therapeutic tools active on MDR tumors, formulate them as nanosystems and verify the efficacy and safety of the new MDRreversing compounds.

Unidades de investigación

• NANOMEDICINA

  

  Investigador Responsable

  Mónica López Fanarraga

  monica.lopez@unican.es